Key facts
- This page summarizes Michael J. Urban's Form 3 filing for Werewolf Therapeutics, Inc. (HOWL).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 13 Mar 2026, 16:11.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The option was granted on June 1, 2023. The shares underlying the option vested as to 25% on May 15, 2024, and the remainder vest in substantially equal monthly installments thereafter through May 15, 2027.
Footnote F2
The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in substantially equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028.
Footnote F3
The option was granted on December 19, 2024, and is fully vested.
Footnote F4
The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in substantially equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney